TY - JOUR
T1 - Trends in age and histology of testicular cancer from 1980-2019
T2 - A single-center study
AU - Yamashita, Shinichi
AU - Koyama, Juntaro
AU - Goto, Takuro
AU - Fujii, Shinji
AU - Yamada, Shigeyuki
AU - Kawasaki, Yoshihide
AU - Kawamorita, Naoki
AU - Mitsuzuka, Koji
AU - Arai, Yoichi
AU - Ito, Akihiro
N1 - Funding Information:
This work was supported in part by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (18K09185).
Publisher Copyright:
© 2020, Tohoku University Medical Press. All rights reserved.
PY - 2020
Y1 - 2020
N2 - Testicular cancer occurs in the testes of the male reproductive system and is the most common cancer in adolescent and young adult (AYA) men. However, recently, there have been more cases of testicular cancer in men older than 40 years. Therefore, trends of testicular cancer during the past 40 years were retrospectively examined, focusing on age and histology. Patients who were diagnosed with testicular cancer at our institution between 1980 and 2019 were enrolled in this study. The patients were divided into groups by the year of diagnosis (1980s, 1990s, 2000s, and 2010s), age at diagnosis (14, 15 to 39, and older than 40 years), and histological type (seminoma and non-seminoma). A total of 563 patients were diagnosed with testicular cancer over the 40-year period. The median age at diagnosis increased continuously, from 28 years to 31 years, 34 years, and 38 years in each period, respectively (p < 0.001). Moreover, most testicular cancer patients were of the AYA generation, whereas the ratio of patients older than 40 years increased significantly since 2000 (p < 0.001). The relative proportion of seminoma also increased more than 50% since 2000. In the seminoma group, median age increased from 31 years to 41 years during the 40-year period (p < 0.001). In conclusion, the age at diagnosis is rising for testicular cancer patients. Clinicians should recognize that testicular cancer affects not only the AYA generation, but there has been a shift to older than 40 years, especially in seminoma.
AB - Testicular cancer occurs in the testes of the male reproductive system and is the most common cancer in adolescent and young adult (AYA) men. However, recently, there have been more cases of testicular cancer in men older than 40 years. Therefore, trends of testicular cancer during the past 40 years were retrospectively examined, focusing on age and histology. Patients who were diagnosed with testicular cancer at our institution between 1980 and 2019 were enrolled in this study. The patients were divided into groups by the year of diagnosis (1980s, 1990s, 2000s, and 2010s), age at diagnosis (14, 15 to 39, and older than 40 years), and histological type (seminoma and non-seminoma). A total of 563 patients were diagnosed with testicular cancer over the 40-year period. The median age at diagnosis increased continuously, from 28 years to 31 years, 34 years, and 38 years in each period, respectively (p < 0.001). Moreover, most testicular cancer patients were of the AYA generation, whereas the ratio of patients older than 40 years increased significantly since 2000 (p < 0.001). The relative proportion of seminoma also increased more than 50% since 2000. In the seminoma group, median age increased from 31 years to 41 years during the 40-year period (p < 0.001). In conclusion, the age at diagnosis is rising for testicular cancer patients. Clinicians should recognize that testicular cancer affects not only the AYA generation, but there has been a shift to older than 40 years, especially in seminoma.
KW - Age
KW - Histology
KW - Non-seminoma
KW - Seminoma
KW - Testicular cancer
UR - http://www.scopus.com/inward/record.url?scp=85095678046&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85095678046&partnerID=8YFLogxK
U2 - 10.1620/tjem.252.219
DO - 10.1620/tjem.252.219
M3 - Article
C2 - 33148936
AN - SCOPUS:85095678046
SN - 0040-8727
VL - 252
SP - 219
EP - 224
JO - Tohoku Journal of Experimental Medicine
JF - Tohoku Journal of Experimental Medicine
IS - 3
ER -